Presentation is loading. Please wait.

Presentation is loading. Please wait.

Date of download: 7/10/2016 Copyright © The American College of Cardiology. All rights reserved. From: Utility of the Wearable Cardioverter-Defibrillator.

Similar presentations


Presentation on theme: "Date of download: 7/10/2016 Copyright © The American College of Cardiology. All rights reserved. From: Utility of the Wearable Cardioverter-Defibrillator."— Presentation transcript:

1 Date of download: 7/10/2016 Copyright © The American College of Cardiology. All rights reserved. From: Utility of the Wearable Cardioverter-Defibrillator in Patients With Newly Diagnosed Cardiomyopathy: A Decade-Long Single-Center Experience J Am Coll Cardiol. 2015;66(23):2607-2613. doi:10.1016/j.jacc.2015.09.079 Number of WCDs Worn Each Year Since its Introduction at UPMC Data for year 10 do not include patients from 3 of 4 UPMC hospitals because the WCD manufacturer would not provide wear-time data on our patients. UPMC = University of Pittsburgh Medical Center; WCD = wearable cardioverter-defibrillator. Figure Legend:

2 Date of download: 7/10/2016 Copyright © The American College of Cardiology. All rights reserved. From: Utility of the Wearable Cardioverter-Defibrillator in Patients With Newly Diagnosed Cardiomyopathy: A Decade-Long Single-Center Experience J Am Coll Cardiol. 2015;66(23):2607-2613. doi:10.1016/j.jacc.2015.09.079 Indications for the WCD Among Patients With ICM The 271 total ischemic cardiomyopathy patients include 141 with new ischemic cardiomyopathy without recent revascularization, 67 with STEMI, 52 with recent CABG or valve surgery, and 11 with NSTEMI. CABG = coronary artery bypass graft; ICM = ischemic cardiomyopathy; NSTEMI = non-ST-segment elevation myocardial infarction; STEMI = ST-segment elevation myocardial infarction; WCD = wearable cardioverter-defibrillator. Figure Legend:

3 Date of download: 7/10/2016 Copyright © The American College of Cardiology. All rights reserved. From: Utility of the Wearable Cardioverter-Defibrillator in Patients With Newly Diagnosed Cardiomyopathy: A Decade-Long Single-Center Experience J Am Coll Cardiol. 2015;66(23):2607-2613. doi:10.1016/j.jacc.2015.09.079 Indications for the WCD Among Patients With NICM Of 254 patients, 207 had new idiopathic cardiomyopathy, 39 had a tachycardia-induced cardiomyopathy, 5 had valvular cardiomyopathy with recent surgical repair or replacement, and 1 each had Takotsubo cardiomyopathy, peripartum cardiomyopathy, and post-transplantation cardiomyopathy. NICM = nonischemic cardiomyopathy; WCD = wearable cardioverter- defibrillator. Figure Legend:

4 Date of download: 7/10/2016 Copyright © The American College of Cardiology. All rights reserved. From: Utility of the Wearable Cardioverter-Defibrillator in Patients With Newly Diagnosed Cardiomyopathy: A Decade-Long Single-Center Experience J Am Coll Cardiol. 2015;66(23):2607-2613. doi:10.1016/j.jacc.2015.09.079 Wearable Cardioverter-Defibrillators for New Cardiomyopathy: Summary of Study Outcomes in 10-Year Follow-Up In this decade-long evaluation, decade-long study outcomes are presented in patients with newly diagnosed cardiomyopathy prescribed a wearable cardioverter-defibrillator. CABG = coronary artery bypass graft; ICD = implantable cardioverter-defibrillator; ICM = ischemic cardiomyopathy; IVCD = intraventricular conduction delay; LBBB = left bundle-branch block; NSTEMI = non−ST- segment elevation myocardial infarction; RBBB = right bundle-branch block; STEMI = ST-segment elevation myocardial infarction. Figure Legend:


Download ppt "Date of download: 7/10/2016 Copyright © The American College of Cardiology. All rights reserved. From: Utility of the Wearable Cardioverter-Defibrillator."

Similar presentations


Ads by Google